1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intragastric Balloons Market
4. Market Overview
4.1. Introduction
4.1.1. Duration Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intragastric Balloons Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Prevalence and Incidence of Obesity in the World
5.3. Regulatory Scenarion in Key Regions/Globally
5.4. Covid-19 Pandemic Impact on Industry
6. Global Intragastric Balloons Market Analysis and Forecast, by Duration
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Duration, 2017–2031
6.3.1. <6 Months
6.3.2. 6 Months
6.3.3. >6 Months
6.4. Market Attractiveness Analysis, by Duration
7. Global Intragastric Balloons Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Fluid-filled Balloons
7.3.2. Gas-filled Balloons
7.4. Market Attractiveness Analysis, by Type
8. Global Intragastric Balloons Market Analysis and Forecast, by Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Administration, 2017–2031
8.3.1. Endoscopy
8.3.2. Swallowable
8.4. Market Attractiveness Analysis, by Administration
9. Global Intragastric Balloons Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Attractiveness Analysis, by End-user
10. Global Intragastric Balloons Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Intragastric Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Duration, 2017–2031
11.2.1. <6 Months
11.2.2. 6 Months
11.2.3. >6 Months
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Fluid-filled Balloons
11.3.2. Gas-filled Balloons
11.4. Market Value Forecast, by Administration, 2017–2031
11.4.1. Endoscopy
11.4.2. Swallowable
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Duration
11.7.2. By Type
11.7.3. By Administration
11.7.4. By End-user
11.7.5. By Country
12. Europe Intragastric Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Duration, 2017–2031
12.2.1. <6 Months
12.2.2. 6 Months
12.2.3. >6 Months
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Fluid-filled Balloons
12.3.2. Gas-filled Balloons
12.4. Market Value Forecast, by Administration, 2017–2031
12.4.1. Endoscopy
12.4.2. Swallowable
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Duration
12.7.2. By Type
12.7.3. By Administration
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Intragastric Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Duration, 2017–2031
13.2.1. <6 Months
13.2.2. 6 Months
13.2.3. >6 Months
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Fluid-filled Balloons
13.3.2. Gas-filled Balloons
13.4. Market Value Forecast, by Administration, 2017–2031
13.4.1. Endoscopy
13.4.2. Swallowable
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Duration
13.7.2. By Type
13.7.3. By Administration
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Intragastric Balloons Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Duration, 2017–2031
14.2.1. <6 Months
14.2.2. 6 Months
14.2.3. >6 Months
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Fluid-filled Balloons
14.3.2. Gas-filled Balloons
14.4. Market Value Forecast, by Administration, 2017–2031
14.4.1. Endoscopy
14.4.2. Swallowable
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Duration
14.7.2. By Type
14.7.3. By Administration
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Intragastric Balloons Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Duration, 2017–2031
15.2.1. <6 Months
15.2.2. 6 Months
15.2.3. >6 Months
15.3. Market Value Forecast, by Type, 2017–2031
15.3.1. Fluid-filled Balloons
15.3.2. Gas-filled Balloons
15.4. Market Value Forecast, by Administration, 2017–2031
15.4.1. Endoscopy
15.4.2. Swallowable
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Duration
15.7.2. By Type
15.7.3. By Administration
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Apollo Endosurgery, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. ReShape Lifesciences, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Spatz FGIA, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Allurion S.a.s.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. ENDALIS
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Helioscopie
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. LEXEL S.R.L.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. CSC MEDSIL
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/